Hexagon Capital Partners’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5
Closed -$1.14K 1902
2024
Q4
$1.14K Buy
+5
New +$1.2K ﹤0.01% 1544

Other funds holding RMD

Hexagon Capital Partners's RMD Position: Q1 2025 in Review

Hexagon Capital Partners sold out of ResMed (RMD) in Q1 2025, closing a stake of 5 shares — an estimated $1.14K sold.

Hexagon Capital Partners first reported a position in RMD in Q4 2024 and held it in 1 quarter. The position peaked at $1.14K in Q4 2024. 885 funds tracked by Wall St. Rank hold RMD as of Q1 2025.

  • Hexagon Capital Partners reported no remaining ResMed position as of Q1 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 5 ResMed shares in Q1 2025, an estimated $1.14K.
  • Hexagon Capital Partners first reported a position in ResMed in Q4 2024 and held it in 1 quarter.
  • Hexagon Capital Partners's ResMed position peaked at $1.14K in Q4 2024.
  • 885 funds tracked by Wall St. Rank held ResMed as of Q1 2025.

Based on Hexagon Capital Partners's 13F filing for Q1 2025, filed 29 Apr 2025.